Vitrolife Registered is expected to publish the balance sheet for the most recent quarter on October 29, 2021, which ended on September 30, 2021.
On average, 1 analyst expects quarterly earnings per share of SEK 0.700. In the same quarter of the previous year, the company had reported earnings of SEK 0.810 per share.
Vitrolife Registered is said to have closed the past quarter with a total turnover of 387.3 million SEK – 2 analysts assume that on average. This corresponds to an increase in sales of 21.04 percent compared to the same quarter of the previous year, in which 320.0 million SEK had been earned.
Looking at the current fiscal year, 3 analysts expect earnings per share of 3.34 SEK on average, compared to 2.64 SEK in the previous year. In terms of turnover, 3 analysts assume on average that in the current fiscal year a total of 1.61 billion SEK will be converted, compared to 1.25 billion SEK in the previous year.